Analysis of human α globin gene mutations that impair binding to the α hemoglobin stabilizing protein

Xiang Yu, Todd L. Mollan, Andrew Butler, Andrew J. Gow, John S. Olson, Mitchell J. Weiss

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Alpha hemoglobin stabilizing protein (AHSP) reversibly binds nascent α globin to maintain its native structure and facilitate its incorporation into hemoglobin A. Previous studies indicate that some naturally occurring human α globin mutations may destabilize the protein by inhibiting its interactions with AHSP. However, these mutations could also affect hemoglobin A production through AHSP-independent effects, including reduced binding to β globin. We analyzed 6 human α globin variants with altered AHSP contact surfaces. Alpha globin amino acid substitutions H103Y, H103R, F117S, and P119S impaired interactions with both AHSP and β globin. These mutations are destabilizing in biochemical assays and are associated with microcytosis and anemia in humans. By contrast, K99E and K99N α globins bind β globin normally but exhibit attenuated binding to AHSP. These mutations impair protein folding and expression in vitro and appear to be mildly destabilizing in vivo. In Escherichia coli and erythroid cells, α globin K99E stability is rescued on coexpression with AHSP mutants in which binding to the abnormal globin chain is restored. Our results better define the biochemical properties of some α globin variants and support the hypothesis that AHSP promotes α globin chain stability during human erythropoiesis.

Original languageEnglish
Pages (from-to)5961-5969
Number of pages9
JournalBlood
Volume113
Issue number23
DOIs
Publication statusPublished - 2009
Externally publishedYes

Fingerprint

Globins
Hemoglobins
Genes
Mutation
Proteins
Hemoglobin A
alpha-Globins
Protein folding
Erythroid Cells
Erythropoiesis
Protein Folding
Mutant Proteins
Amino Acid Substitution
Escherichia coli
Anemia
Assays
Membrane Proteins
Substitution reactions
Amino Acids

ASJC Scopus subject areas

  • Hematology
  • Biochemistry
  • Cell Biology
  • Immunology

Cite this

Yu, X., Mollan, T. L., Butler, A., Gow, A. J., Olson, J. S., & Weiss, M. J. (2009). Analysis of human α globin gene mutations that impair binding to the α hemoglobin stabilizing protein. Blood, 113(23), 5961-5969. https://doi.org/10.1182/blood-2008-12-196030

Analysis of human α globin gene mutations that impair binding to the α hemoglobin stabilizing protein. / Yu, Xiang; Mollan, Todd L.; Butler, Andrew; Gow, Andrew J.; Olson, John S.; Weiss, Mitchell J.

In: Blood, Vol. 113, No. 23, 2009, p. 5961-5969.

Research output: Contribution to journalArticle

Yu, X, Mollan, TL, Butler, A, Gow, AJ, Olson, JS & Weiss, MJ 2009, 'Analysis of human α globin gene mutations that impair binding to the α hemoglobin stabilizing protein', Blood, vol. 113, no. 23, pp. 5961-5969. https://doi.org/10.1182/blood-2008-12-196030
Yu, Xiang ; Mollan, Todd L. ; Butler, Andrew ; Gow, Andrew J. ; Olson, John S. ; Weiss, Mitchell J. / Analysis of human α globin gene mutations that impair binding to the α hemoglobin stabilizing protein. In: Blood. 2009 ; Vol. 113, No. 23. pp. 5961-5969.
@article{c6db96d78ff14266b74cdff8cc241318,
title = "Analysis of human α globin gene mutations that impair binding to the α hemoglobin stabilizing protein",
abstract = "Alpha hemoglobin stabilizing protein (AHSP) reversibly binds nascent α globin to maintain its native structure and facilitate its incorporation into hemoglobin A. Previous studies indicate that some naturally occurring human α globin mutations may destabilize the protein by inhibiting its interactions with AHSP. However, these mutations could also affect hemoglobin A production through AHSP-independent effects, including reduced binding to β globin. We analyzed 6 human α globin variants with altered AHSP contact surfaces. Alpha globin amino acid substitutions H103Y, H103R, F117S, and P119S impaired interactions with both AHSP and β globin. These mutations are destabilizing in biochemical assays and are associated with microcytosis and anemia in humans. By contrast, K99E and K99N α globins bind β globin normally but exhibit attenuated binding to AHSP. These mutations impair protein folding and expression in vitro and appear to be mildly destabilizing in vivo. In Escherichia coli and erythroid cells, α globin K99E stability is rescued on coexpression with AHSP mutants in which binding to the abnormal globin chain is restored. Our results better define the biochemical properties of some α globin variants and support the hypothesis that AHSP promotes α globin chain stability during human erythropoiesis.",
author = "Xiang Yu and Mollan, {Todd L.} and Andrew Butler and Gow, {Andrew J.} and Olson, {John S.} and Weiss, {Mitchell J.}",
year = "2009",
doi = "10.1182/blood-2008-12-196030",
language = "English",
volume = "113",
pages = "5961--5969",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "23",

}

TY - JOUR

T1 - Analysis of human α globin gene mutations that impair binding to the α hemoglobin stabilizing protein

AU - Yu, Xiang

AU - Mollan, Todd L.

AU - Butler, Andrew

AU - Gow, Andrew J.

AU - Olson, John S.

AU - Weiss, Mitchell J.

PY - 2009

Y1 - 2009

N2 - Alpha hemoglobin stabilizing protein (AHSP) reversibly binds nascent α globin to maintain its native structure and facilitate its incorporation into hemoglobin A. Previous studies indicate that some naturally occurring human α globin mutations may destabilize the protein by inhibiting its interactions with AHSP. However, these mutations could also affect hemoglobin A production through AHSP-independent effects, including reduced binding to β globin. We analyzed 6 human α globin variants with altered AHSP contact surfaces. Alpha globin amino acid substitutions H103Y, H103R, F117S, and P119S impaired interactions with both AHSP and β globin. These mutations are destabilizing in biochemical assays and are associated with microcytosis and anemia in humans. By contrast, K99E and K99N α globins bind β globin normally but exhibit attenuated binding to AHSP. These mutations impair protein folding and expression in vitro and appear to be mildly destabilizing in vivo. In Escherichia coli and erythroid cells, α globin K99E stability is rescued on coexpression with AHSP mutants in which binding to the abnormal globin chain is restored. Our results better define the biochemical properties of some α globin variants and support the hypothesis that AHSP promotes α globin chain stability during human erythropoiesis.

AB - Alpha hemoglobin stabilizing protein (AHSP) reversibly binds nascent α globin to maintain its native structure and facilitate its incorporation into hemoglobin A. Previous studies indicate that some naturally occurring human α globin mutations may destabilize the protein by inhibiting its interactions with AHSP. However, these mutations could also affect hemoglobin A production through AHSP-independent effects, including reduced binding to β globin. We analyzed 6 human α globin variants with altered AHSP contact surfaces. Alpha globin amino acid substitutions H103Y, H103R, F117S, and P119S impaired interactions with both AHSP and β globin. These mutations are destabilizing in biochemical assays and are associated with microcytosis and anemia in humans. By contrast, K99E and K99N α globins bind β globin normally but exhibit attenuated binding to AHSP. These mutations impair protein folding and expression in vitro and appear to be mildly destabilizing in vivo. In Escherichia coli and erythroid cells, α globin K99E stability is rescued on coexpression with AHSP mutants in which binding to the abnormal globin chain is restored. Our results better define the biochemical properties of some α globin variants and support the hypothesis that AHSP promotes α globin chain stability during human erythropoiesis.

UR - http://www.scopus.com/inward/record.url?scp=67651100891&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67651100891&partnerID=8YFLogxK

U2 - 10.1182/blood-2008-12-196030

DO - 10.1182/blood-2008-12-196030

M3 - Article

VL - 113

SP - 5961

EP - 5969

JO - Blood

JF - Blood

SN - 0006-4971

IS - 23

ER -